SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia
4 references·16 citing·49 second hop
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia (2007)Efficacy and Safety of Doxepin 1 mg, 3 mg…Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits (2005)Sedative hypnotics in older p…Clinical Correlates of Insomnia in Patients With Chronic Illness (1998)Clinical Correlates of Insomn…Prevalence of DSM-IV diagnostic criteria of insomnia: Distinguishing insomnia related to mental disorders from sleep disorders (1997)Prevalence of DSM-IV diagnost…Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults (1996)Sleep disturbance and psychia…Connecting insufficient sleep and insomnia with metabolic dysfunction (2022)Connecting insufficient sleep…The assessment and management of insomnia: an update (2019)The assessment and management…Antidepressants for insomnia in adults (2018)Antidepressants for insomnia …Insomnia: Pharmacologic Therapy. (2017)Insomnia: Pharmacologic Thera…Doxepin for insomnia: A systematic review of randomized placebo-controlled trials (2014)Doxepin for insomnia: A syste…Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications (2013)Review of the histamine syste…Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease – A randomized study (2013)Doxepin and cognitive behavio…Sleep and Antidepressant Treatment (2012)Sleep and Antidepressant Trea…Insomnia Pharmacotherapy (2012)Insomnia PharmacotherapyHistamine-1 receptor antagonism for treatment of insomnia (2012)Histamine-1 receptor antagoni…Efficacy and safety of doxepin 6mg in a four-week outpatient trial of elderly adults with chronic primary insomnia (2011)Efficacy and safety of doxepi…Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia (2011)Efficacy and Safety of Doxepi…Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia (2010)Efficacy and Safety of Doxepi…A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice (2009)A compendium of placebo-contr…Selective Histamine H1Antagonism:Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines (2008)Selective Histamine H1Antagon…Novel therapeutic usage of low-dose doxepin hydrochloride (2007)Novel therapeutic usage of lo…Manual for the Wechsler Adult Intelligence Scale. (1955)A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects (1968)Epidemiology of insomnia: what we know and what we still need to learn (2002)Advances in the management of chronic insomnia (2016)Insomnia in Elderly Patients: Recommendations for Pharmacological Management (2018)Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders (1989)Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? (1989)Psychological And Behavioral Treatment Of Insomnia: Update Of The Recent Evidence (1998–2004) (2006)Pharmacotherapy Treatment Options for Insomnia: A Primer for Clinicians (2015)Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder (2020)The functioning and well-being of depressed patients. Results from the Medical Outcomes Study (1989)The MOS 36-Item Short-Form Health Survey (SF-36) (1993)The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups (1994)Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders (2005)Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents (2008)Comorbidity of insomnia and depression (2009)Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Insomnia: Definition, Prevalence, Etiology, and Consequences (2007)Sleep Patterns and Predictors of Disturbed Sleep in a Large Population of College Students (2009)Diagnostic and Statistical Manual of Mental Disorders (2013)Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline (2017)Doxepin in the Treatment of Primary Insomnia (2001)Diagnosis and Treatment of Sleep Disorders in Older Adults (2006)Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time (2008)Insomnia: Prevalence, Impact, Pathogenesis, Differential Diagnosis, and Evaluation (2008)Low-Dose Doxepin (2010)Operating Characteristics of a Rank Correlation Test for Publication Bias (1994)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders (2010)Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review (2012)Older Adults' Reasons for Using Technology while Aging in Place (2015)The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 (2023)The International Classification of Sleep Disorders (1991)Sleep Problems, Comorbid Mental Disorders, and Role Functioning in the National Comorbidity Survey Replication (2006)Sleep-Related Problems Among Children and Adolescents With Anxiety Disorders (2007)The Direct and Indirect Costs of Untreated Insomnia in Adults in the United States (2007)Functional Neuroimaging Evidence for Hyperarousal in Insomnia (2004)Quetiapine for insomnia: A review of the literature (2014)The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research (1989)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The efficacy and safety of dual orexin receptor antagonists in primary insomnia: A systematic review and network meta-analysis (2021)Comparative efficacy and acceptability of cognitive behavioral therapy delivery formats for insomnia in adults: A systematic review and network meta-analysis (2022)Management of Insomnia (2024)A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale (1991)Diagnostic and Statistical Manual of Mental Disorders (2013)Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders (2020)The Impact of the COVID-19 Pandemic on Students’ Mental Health and Sleep in Saudi Arabia (2021)Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder (2022)
this work references cited by second hop

References

  • 1996Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults1,830 cited
  • 2005Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits1,158 cited
  • 1998Clinical Correlates of Insomnia in Patients With Chronic Illness480 cited
  • 1997Prevalence of DSM-IV diagnostic criteria of insomnia: Distinguishing insomnia related to mental disorders from sleep disorders423 cited

Cited by

  • 2019The assessment and management of insomnia: an update255 cited
  • 2008Selective Histamine H1Antagonism:Novel Hypnotic and Pharmacologic Actions Challenge Classical Notions of Antihistamines241 cited
  • 2018Antidepressants for insomnia in adults208 cited
  • 2010Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia192 cited
  • 2007Novel therapeutic usage of low-dose doxepin hydrochloride184 cited
  • 2009A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for U.S. clinical practice179 cited
  • 2013Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease – A randomized study166 cited
  • 2012Sleep and Antidepressant Treatment142 cited
  • 2012Insomnia Pharmacotherapy133 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2017
Insomnia: Pharmacologic Therapy.
132 cited
  • 2011Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia129 cited
  • 2014Doxepin for insomnia: A systematic review of randomized placebo-controlled trials126 cited
  • 2022Connecting insufficient sleep and insomnia with metabolic dysfunction110 cited
  • 2013Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications101 cited
  • 2012Histamine-1 receptor antagonism for treatment of insomnia94 cited
  • 2011Efficacy and safety of doxepin 6mg in a four-week outpatient trial of elderly adults with chronic primary insomnia90 cited